penny：后面会有正式的发布会宣布EUA

...
While EUA Indovac as a booster vaccine, Penny said, is currently still in the clinical trial stage. In addition, BPOM has also pocketed an EUA for the Ethane vaccine, both used as a primer and a booster. This Covid-19 vaccine was developed with an mRNA platform.
Penny claims that, although mRNA-based, the Ethane vaccine can be stored in temperatures of 2-8 degrees Celsius. This vaccine is also produced in Indonesia.
"This is an mRNA vaccine that can be stored 2-8 degrees Celsius. So I think it's a good technology too, we're already in Indonesia. It's also got an EUA for boosters and also for primers," Penny said. 这里意思似乎像是已经批了？
As for the Red and White vaccine, Penny said the EUA will be published no later than early October 2022. 
"The red and white vaccine is still in finalization, jd soon. It's September, the beginning of October will get an EUA," Penny said.
...

看赞数就知道多少散户流下了激动的泪水，虽然都知道对股价没有什么帮助，意义大于实质，但是起码告诉那些觉得我们买的是垃圾的人，沃森不是临床生物，不是骗子生物，是情怀生物，我们也是有情怀有格局的人，赚钱算什么

哭一哈，熬了一年多对自己有个交代

舍得兄弟和Penny姐姐都很靠谱，不像那个刚刚下课的推进姐，说今年9月就不会是10月

借个肩膀，让我哭一会儿

热烈祝贺印度尼西亚人民拥有了一款全球唯一的可以常规冷链储存运输的获得清真认证的mRNA新冠疫苗～这话没毛病吧？

虽然知道这个消息对股价没多大用，但是依然感动得想哭，这是老父亲的泪啊。

jayavac是沃森合作的？

买了这个股票现在已经负资产，等到海枯石烂才能上市吗开动挖掘机也挖不到什么东西(感觉在自掘坟墓），补充两则新闻
2022-08-26 GMP/CPOB准备是到啥阶段了？
BPOM is ready to assist local vaccine developers who work with global pharmaceutical companies for good manufacturing practice (GMP) or good drug production methods (CPOB) for vaccines produced in Indonesia.
REPUBLIKA.CO.ID, JAKARTA -- Head of the Indonesian Food and Drug Supervisory Agency (BPOM) Penny K Lukito said that a private company PT Etana Biotechnologies Indonesia is pioneering to produce a Covid-19 vaccine with an mRNA platform in Indonesia. He said it would be made possible through technology transfer from a number of global pharmaceutical companies.
PT Etana is in the process of obtaining certification on how to produce mRNA vaccines, both in the upstream and downstream sectors with technology transfer," penny said in the agenda of the Domestic Drug Development Workshop at the Ayana MidPlaza Hotel Jakarta, Friday (26/8/2022).
...
Penny said the development of domestic mRNA vaccines by PT Etana Biotechnologies Indonesia was assisted by global pharmaceutical companies from China, namely Abogen Biosciences Co Ltd and Yuxi Walvax through technology transfer. According to Penny, the two global pharmaceutical companies are clinically proven to be able to produce mRNA-platform vaccines with good quality.
"BPOM is ready to assist in good manufacturing practice (GMP) or good drug production methods (CPOB) vaccines produced in Indonesia," he said. 网页链接
2022-09-27 这是要大干一场了吗
印尼生物制药公司Etana完成数千万美元B轮融资，云锋基金领投
9月27日，印度尼西亚生物制药公司PT Etana Biotechnologies Indonesia（Etana）宣布完成数千万美元B轮融资，由云锋基金领投。本轮融资将主要用于单克隆抗体药物（mAb）、高端疫苗产品管线的本地化临床和生产，团队能力建设及产能扩张等，加速完善Etana在印尼及东南亚地区的产品布局及本土化生产能力。
Etana成立于2014年，致力于为印尼及东南亚市场研发、生产和销售高质量、创新且可负担的生物药，满足东南亚患者对优质医疗产品和治疗方案的需求。凭借在生物制药领域的多年深耕和积累，Etana目前建立了丰富的产品管线，治疗领域涵盖代谢性疾病、自身免疫疾病、传染病疫苗、肿瘤等。
Etana专注于提升印尼本土化的生物制药生产能力，正在建立单克隆抗体、高端疫苗及其它生物制药的生产体系。自2020年以来，Etana相继完成了重组蛋白技术、mRNA技术平台的本地化引进，并陆续开展了本地临床和报批工作。